206 related articles for article (PubMed ID: 14672806)
21. Region-dependent G-protein activation by kappa-opioid receptor agonists in the mouse brain.
Mizoguchi H; Leitermann RJ; Narita M; Nagase H; Suzuki T; Tseng LF
Neurosci Lett; 2004 Feb; 356(2):145-7. PubMed ID: 14746884
[TBL] [Abstract][Full Text] [Related]
22. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice.
Sounvoravong S; Takahashi M; Nakashima MN; Nakashima K
J Pharmacol Sci; 2004 Mar; 94(3):305-12. PubMed ID: 15037816
[TBL] [Abstract][Full Text] [Related]
23. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
Laurido C; Hernandez A; Perez H
Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
[TBL] [Abstract][Full Text] [Related]
24. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
Bhargava HN; Thorat SN
Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
[TBL] [Abstract][Full Text] [Related]
25. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice.
Sakakihara M; Imamachi N; Saito Y
Reg Anesth Pain Med; 2016; 41(1):69-74. PubMed ID: 26587674
[TBL] [Abstract][Full Text] [Related]
26. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
Bhargava HN; Ramarao P; Gulati A
Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
[TBL] [Abstract][Full Text] [Related]
27. Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats.
Mori T; Nomura M; Yoshizawa K; Nagase H; Sawaguchi T; Narita M; Suzuki T
J Pharmacol Sci; 2006 Feb; 100(2):157-61. PubMed ID: 16474203
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
29. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Cao YJ; Bhargava HN
Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464
[TBL] [Abstract][Full Text] [Related]
30. Mu and kappa opioid receptor agonists antagonize icilin-induced wet-dog shaking in rats.
Werkheiser JL; Rawls SM; Cowan A
Eur J Pharmacol; 2006 Oct; 547(1-3):101-5. PubMed ID: 16945367
[TBL] [Abstract][Full Text] [Related]
31. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
D'Anci KE; Gerstein AV; Kanarek RB
Pharmacol Biochem Behav; 2000 Jun; 66(2):343-6. PubMed ID: 10880688
[TBL] [Abstract][Full Text] [Related]
32. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
Yamamoto T; Ohno M; Ueki S
Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
[TBL] [Abstract][Full Text] [Related]
33. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
Bhargava HN; Cao YJ; Zhao GM
Brain Res; 1997 Mar; 752(1-2):234-8. PubMed ID: 9106462
[TBL] [Abstract][Full Text] [Related]
34. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
Ko MC; Husbands SM
J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
[TBL] [Abstract][Full Text] [Related]
35. Novel selective κ agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion.
Wei YY; Ma Y; Yao SY; Kong LH; Liu X; Chai JR; Chen J; Li W; Wang YJ; Shao LM; Liu JG
Acta Pharmacol Sin; 2022 Jun; 43(6):1372-1382. PubMed ID: 34493813
[TBL] [Abstract][Full Text] [Related]
36. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
Tsuji M; Takeda H; Matsumiya T; Nagase H; Narita M; Suzuki T
Life Sci; 2001 Mar; 68(15):1717-25. PubMed ID: 11270618
[TBL] [Abstract][Full Text] [Related]
37. Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives.
Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K
Bioorg Med Chem Lett; 2017 Aug; 27(16):3920-3924. PubMed ID: 28688957
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Bhargava HN; Thorat SN
Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
[TBL] [Abstract][Full Text] [Related]
39. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
40. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
Bhargava HN; Matwyshyn G; Ramarao P
Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
